Skip to main content
. Author manuscript; available in PMC: 2022 Oct 10.
Published in final edited form as: Gut. 2018 Aug 14;68(6):996–1002. doi: 10.1136/gutjnl-2017-315136

Table 4:

Five Components of IBS-SS: Baseline vs. Glutamine Treatment

Mean + SD Pre-Post Change ( Mean + SD)
Abdominal Distension/Bloating
Baseline 57.54 ± 13.77 −5.33 ± 11.85
Treatment endpoint 52.20 ± 13.60 p-value = .0017
Abdominal Pain Frequency
Baseline 57.93 ± 14.40 −17.65 ± 18.73
Treatment endpoint 40.28 ± 12.65 p-value < .0001
Abdominal Pain Severity
Baseline 62.80 ± 16.87 −34.76 ± 23.26
Treatment endpoint 28.04 ± 13.09 p-value < .0001
Quality of Life
Baseline 63.26 ± 16.60 −33.22 ± 23.10
Treatment endpoint 30.04 ± 12.95 p-value < .0001
Satisfaction with Bowel Habits
Baseline 59.31 ± 17.94 −28.56 ± 24.18
Treatment endpoint 30.76 ± 14.22 p-value < .0001
+

The p value was computed using the paired t test.